Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Cycloset in Pediatric T2DM
NCT02078440Phase 1Completed
- Sponsor
- VeroScience
- Start
- Jan 2014
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bromocriptine in type 2 diabetes mellitus (T2DM), sponsored by VeroScience. Primary endpoint: Pharmacokinetics at 36 hours. Started Jan 2014; status: completed.
02
Drugs
bromocriptine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02078440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078440.